Literature DB >> 6388756

Apolipoprotein C-II deficiency associated with nonfunctional mutant forms of apolipoprotein C-II.

G F Maguire, J A Little, G Kakis, W C Breckenridge.   

Abstract

Two previously unidentified apolipoproteins (apo) designated apo C-II-X and C-II-Y have been found in plasma of homozygotes and obligate heterozygotes of a family with apo C-II deficiency. Because the plasma of homozygotes do not activate lipoprotein lipase, apo C-II-X and C-II-Y are apparently nonfunctional. These apolipoproteins have isoelectric focusing points of 5.15 and 5.54, respectively, compared with 4.88 and 4.74 for the known isomorphs, C-II-1 and C-II-2, respectively. They have approximately similar molecular weights to apo C-II-1 and C-II-2 on two-dimensional sodium dodecyl sulphate-glycerol-polyacrylamide slab gel electrophoresis. They do not form insoluble antigen-antibody complexes with antibodies to apo C-II in single antibody immunodiffusion or electroimmunoassay systems. However, using a double-antibody technique in which immunoblotting is coupled with polyacrylamide isoelectric focusing slab gel electrophoresis, apo C-II-1, C-II-2, C-II-X, and C-II-Y have similar reactivity with antibodies to apo C-II. In this family the presence of apo C-II-X and C-II-Y discriminates obligate heterozygotes from normal subjects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388756     DOI: 10.1139/o84-108

Source DB:  PubMed          Journal:  Can J Biochem Cell Biol        ISSN: 0714-7511


  7 in total

1.  Purification, cloning and nucleotide sequence determination of cynomolgus monkey apolipoprotein C-II: comparison to the human sequence.

Authors:  B E Whitted; C K Castle; H G Polites; G W Melchior; K R Marotti
Journal:  Mol Cell Biochem       Date:  1989-10-05       Impact factor: 3.396

2.  Primary lipoprotein-lipase-activity deficiency: clinical investigation of a French Canadian population.

Authors:  C Gagné; L D Brun; P Julien; S Moorjani; P J Lupien
Journal:  CMAJ       Date:  1989-02-15       Impact factor: 8.262

3.  Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease.

Authors:  P W Connelly; G F Maguire; J A Little
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

4.  A novel type hypertriglyceridemia observed in FLS mice.

Authors:  Masaya Takahashi; Toshiji Saibara; Yoshihisa Nemoto; Masafumi Ono; Naoaki Akisawa; Shinji Iwasaki; Katsumi Toda; Yasuhiro Ogawa; Akihiko Wakatsuki; Shuichiro Inagaki; Saburo Onishi
Journal:  Lipids       Date:  2003-07       Impact factor: 1.880

5.  Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.

Authors:  G Baggio; E Manzato; C Gabelli; R Fellin; S Martini; G B Enzi; F Verlato; M R Baiocchi; D L Sprecher; M L Kashyap
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

6.  Structure of apolipoprotein C-IIToronto, a nonfunctional human apolipoprotein.

Authors:  P W Connelly; G F Maguire; T Hofmann; J A Little
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  A deletion of one nucleotide results in functional deficiency of apolipoprotein CII (apo CII Toronto).

Authors:  D W Cox; D E Wills; F Quan; P N Ray
Journal:  J Med Genet       Date:  1988-10       Impact factor: 6.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.